Roche Holding AG (OTCQX International Premier:RHHBF)
| 366.51 Delayed Data As of Jan 26 |  -3.47 / -0.94%Today’s Change | 340.10 Today|||52-Week Range 466.14 | -5.90% Year-to-Date |
Latest RHHBF News | Press Releases
| J&J (JNJ) Q4 Earnings Beat, Sales Miss, 2023 EPS View Upbeat Jan 24 / Zacks.com - Paid Partner Content | Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal Jan 19 / Zacks.com - Paid Partner Content |
| FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug Jan 20 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy Jan 17 / Zacks.com - Paid Partner Content |
| Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication Jan 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 369.98 |
| Today’s open | 366.51 |
| Day’s range | 366.51 - 366.51 |
| Volume | 5 |
| Average volume (3 months) | 79 |
| Market cap | $39.1B |
Data as of 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +0.63% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +10.55% |
| P/E ratio | -- |
| Price/Sales | 5.62 |
| Price/Book | 10.91 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $68.7B |
| Annual profit (last year) | $15.2B |
| Net profit margin | 22.18% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
Chart unavailable
